Q&A With Robert Eckel From the University of Colorado: Major Medical Organizations Largely Agree on New Cholesterol Guidelines

Video

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

Robert Eckel, MD, from the University of Colorado Anschutz Medical Campus discussed new guidelines that have been adopted by the American Heart Association, the American College of Cardiology, and the American Diabetes Assocation during the latter's 75th Annual Scientific Sessions in Boston. While there are only some minor disagreements, Eckel said one major difference is whether a risk management program could help patients monitor their health.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.